세계의 국소 약물전달 시장 - 규모, 점유율, 성장 분석 : 제품별, 투여 경로별, 사용 시설별, 지역별 산업 예측(2024-2031년)

Global Topical Drug Delivery Market size was valued at USD 207.85 billion in 2022 and is poised to grow from USD 226.76 billion in 2023 to USD 455.17 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031).

The global topical drug delivery market has seen remarkable growth, driven by the increasing prevalence of skin conditions such as acne, psoriasis, eczema, and dermatitis that necessitate targeted treatment. The rising demand for effective treatment options, coupled with an aging population facing chronic issues like arthritis and diabetic ulcers, has accelerated the adoption of these non-invasive delivery systems. Topical drug delivery not only facilitates pain management and wound healing but also enhances the delivery of active ingredients, such as retinoids and hyaluronic acid, crucial for combating signs of aging. Additionally, the surge in cosmetic dermatology interest has spurred innovation in topical delivery technologies, positioning this market for sustained expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Drug Delivery Market Segmental Analysis

Global Topical Drug Delivery Market is segmented by product, route of administration, facility of use and region. Based on product, the market is segmented into semi-solid formulations, liquid formulations, solid formulations and transdermal products. Based on route of administration, the market is segmented into dermal drug delivery, ophthalmic drug delivery, vaginal drug delivery, rectal drug delivery and nasal drug delivery. Based on facility of use, the market is segmented into homecare settings, hospitals & clinics, burn centers and other facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market is significantly driven by the convenience and non-invasive nature of this method for administering medications. By providing an alternative to injections and oral dosage forms, topical drug delivery appeals to patients who experience anxiety around needles or seek a more comfortable and straightforward treatment process. This ease of use not only improves patient adherence to prescribed therapies but also enhances the overall treatment experience. This method is particularly beneficial for children and individuals with a fear of needles, making topical formulations a favored choice in contemporary healthcare.

Restraints in the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market faces significant restraints primarily due to formulation challenges that arise during the development of stable and effective topical products. Key factors such as drug solubility, stability, and compatibility with excipients complicate the formulation process, necessitating a delicate balance to achieve the desired release profile. These complexities can affect the overall availability and commercial success of topical drug formulations, as they must comply with rigorous quality standards and regulatory requirements while also ensuring that they deliver optimal therapeutic efficacy. Consequently, these formulation challenges pose a barrier to innovation and market growth in the sector.

Market Trends of the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market is witnessing robust growth, propelled by the rising incidence of skin diseases and an ageing population that demands effective treatment options. The shift towards non-invasive drug delivery methodologies enhances patient compliance and accessibility, further fueling market expansion. Innovative technologies like microneedles and nanocarriers are enhancing drug efficacy and penetration, creating new avenues for growth. However, challenges such as high product costs and stringent regulatory hurdles could impede progress. Despite these obstacles, the market remains optimistic, driven by continuous technological advancements and growing awareness of the benefits of topical drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis

Global Topical Drug Delivery Market Size by Product & CAGR (2024-2031)

• Market Overview
• Semi-Solid Formulations
  • Ointments
  • Creams
  • Lotions
  • Gels
  • Pastes
• Liquid Formulations
  • Suspensions
  • Solutions
• Solid Formulations
  • Powders
  • Suppositories
• Transdermal Products
  • Transdermal Patches
  • Transdermal Semi-Solids

Global Topical Drug Delivery Market Size by Route Of Administration & CAGR (2024-2031)

• Market Overview
• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Vaginal Drug Delivery
• Rectal Drug Delivery
• Nasal Drug Delivery

Global Topical Drug Delivery Market Size by Facility Of Use & CAGR (2024-2031)

• Market Overview
• Homecare Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

Global Topical Drug Delivery Market Size & CAGR (2024-2031)

• North America (Product, Route Of Administration, Facility Of Use)
  • USA
  • Canada
• Europe (Product, Route Of Administration, Facility Of Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route Of Administration, Facility Of Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route Of Administration, Facility Of Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route Of Administration, Facility Of Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Glenmark Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Private Limited (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hisamitsu Pharmaceuticals Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (Mylan N.V.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crescita Therapeutics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lead Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma L.P. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lavipharm (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations